Research Analysts’ updated eps estimates for Wednesday, November 6th:
Arbutus Biopharma (NASDAQ:ABUS) had its target price boosted by JMP Securities to $5.00. They currently have a buy rating on the stock.
eHealth (NASDAQ:EHTH) was upgraded by analysts at Craig Hallum from a hold rating to a buy rating. They currently have $7.00 price target on the stock, up from their previous price target of $5.00.
International Flavors & Fragrances (NYSE:IFF) had its price target boosted by UBS Group AG from $108.00 to $111.00. They currently have a neutral rating on the stock.
InterRent Real Estate Investment Trust (TSE:IIP.UN) was upgraded by analysts at TD Securities from a hold rating to a buy rating. They currently have C$14.00 target price on the stock.
IO Biotech (NASDAQ:IOBT) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $12.00 target price on the stock.
JELD-WEN (NYSE:JELD) had its target price reduced by UBS Group AG from $19.00 to $15.00. UBS Group AG currently has a buy rating on the stock.
Jack Henry & Associates (NASDAQ:JKHY) had its equal weight rating reaffirmed by analysts at Stephens. They currently have a $170.00 target price on the stock.
Hello Group (NASDAQ:MOMO) was downgraded by analysts at Bank of America Co. from a buy rating to an underperform rating.
NXP Semiconductors (NASDAQ:NXPI) had its price target trimmed by UBS Group AG from $285.00 to $275.00. The firm currently has a buy rating on the stock.
Qualys (NASDAQ:QLYS) had its price target increased by UBS Group AG from $140.00 to $160.00. They currently have a neutral rating on the stock.
Qualys (NASDAQ:QLYS) had its hold rating reissued by analysts at Westpark Capital.
uniQure (NASDAQ:QURE) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $25.00 target price on the stock.
Revolve Group (NYSE:RVLV) had its price target raised by UBS Group AG from $25.00 to $30.00. They currently have a neutral rating on the stock.
Westlake (NYSE:WLK) had its price target lowered by UBS Group AG from $160.00 to $144.00. They currently have a neutral rating on the stock.
Xometry (NASDAQ:XMTR) had its price target raised by UBS Group AG from $20.00 to $22.00. They currently have a neutral rating on the stock.
Yum! Brands (NYSE:YUM) had its hold rating reiterated by analysts at TD Cowen. The firm currently has a $145.00 target price on the stock.
Receive News & Ratings for Arbutus Biopharma Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arbutus Biopharma Co and related companies with MarketBeat.com's FREE daily email newsletter.